Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma
Abstract We aimed to determine whether pretreatment squamous cell carcinoma antigen (SCC-Ag) levels and the average logarithmic change in SCC-Ag levels ( $$\frac{{\Delta \log \left( {{\text{SCC-Ag}}} \right)}}{{\Delta {\text{time}}}}$$ Δ log SCC-Ag Δ time ) after concurrent chemoradiotherapy (CCRT)...
Main Authors: | Oyeon Cho, Mison Chun, Suk-Joon Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-59412-w |
Similar Items
-
Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Oyeon Cho, et al.
Published: (2017-10-01) -
Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
by: Huang Eng-Yen, et al.
Published: (2012-01-01) -
Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Ge Hu, et al.
Published: (2023-07-01) -
Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma
by: Joana Moreira-Barros, et al.
Published: (2018-12-01) -
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)